… as a one-off disease-modifying therapy for aggressive forms of multiple sclerosis (MS). We report real-world effectiveness of AHSCT for MS in the…
Multiple Sclerosis
This disease is selected. Its supporting articles are shown below.
Articles mentioning Multiple Sclerosis
152 articles · page 7 of 13…valuating the efficacy of disease-modifying therapies (DMTs) in multiple sclerosis (MS) using French registry data.Methods This multicentre, retro…
…port the case of a male patient in his 30s with newly diagnosed multiple sclerosis who initially responded well to high-dose corticosteroids and w…
…The 2024 revisions to the McDonald criteria for multiple sclerosis (MS) add the optic nerve as a fifth central nervous system loca…
… sclerosis (MS), neuromyelitis optica spectrum disease (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and autoimmune glial fibrillary acidic protein astrocyt…
…adults is usually caused by an immune-mediated disease, such as multiple sclerosis, neuromyelitis optica spectrum disorder or myelin oligodendrocy…
…Background Increased use of healthcare before multiple sclerosis (MS) onset indicates a prodromal phase. Data on the prodromal p…
…h outcomes, especially in chronic neurological diseases such as multiple sclerosis (MS). Insufficient HL may impair the ability of patients to man…
…g BCD therapy have limited antibody boosting following repeated COVID-19 vaccination. However, the absence of severe outcomes in pwMS, d…
…Background Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin…
…ch biomarkers.Methods and analysis People living with dementia, motor neuron disease, multiple sclerosis and Parkinson’s disease are eligible to par…
…ibution and adipokine profiles may influence immune activity in multiple sclerosis (MS). We investigated relationships between adipokines, inflamm…